New New Oral Anticoagulants 2014
New Oral Anticoagulants
Advances Against Aspergillosis Istanbul, 2012 Anti-fungal therapeutic drug monitoring and azole dose modification Tim Felton.
PHARMACOKINETIC DRUG INTERACTIONS. DRUGS REMOVED FROM THE MARKET DURING THE 1990s DRUGCATEGORYREASON Astemizoleantihistamineserious metabolic drug intxns.
Andrew Gilbert Quality Use of Medicines and Pharmacy Research Centre Sansom Institute University of South Australia Effectiveness of collaborative medicine.
Implementing Medication Reconciliation in Long-Term Care O’Connell Date: April 14, 2008 by Bonnie Walker Risk Manager /Patient Safety Advisor.
ASA - Is there a Primary Prevent Indication in Diabetes? Contemporary Therapeutic Issues in Cardiovascular Disease Saturday, May 8 th, 2010 Patrick Robertson,
Nitrattherapie und Nitratresistenz – Implikationen für Diabetes mellitus und KHK Nitrattherapie und Nitratresistenz – Implikationen für Diabetes mellitus.
Momento científico 04/Setembro/2014. Antipsicóticos Atípicos X riscos Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis.
Diabetes and Cardiovascular Risk La lezione dai grandi studi di intervento.
RIAIP 2008 11 bambini dagli 8 ai 10 anni con pregressa anafilassi 11 puffs di adrenalina spray (non in commercio in Italia) Adrenalina per via inalatoria.
Prospettive dell’informazione indipendente sui farmaci Maria Font Dialogo sui Farmaci International Society of Drug Bulletins (ISDB) Bologna, 18.11.2009.
